These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16112032)

  • 1. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
    Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
    Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor stimulation induces higher TNF-alpha secretion in peripheral blood mononuclear cells from patients with hyper IgE syndrome.
    Yeganeh M; Henneke P; Rezaei N; Ehl S; Thiel D; Matamoros N; Pietrogrande C; Espanol T; Litzman J; Franco JL; Sanal O; Kilic SS; Breborowicz A; Plebani A; Renner E; Rothenfusser S; Hawn TR; Woellner C; Grimbacher B
    Int Arch Allergy Immunol; 2008; 146(3):190-4. PubMed ID: 18268386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.
    Minegishi Y; Karasuyama H
    Int Immunol; 2009 Feb; 21(2):105-12. PubMed ID: 19088064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
    Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
    Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
    Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
    Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis.
    Chang JH; Hampartzoumian T; Everett B; Lloyd A; McCluskey PJ; Wakefield D
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1711-7. PubMed ID: 17389503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
    Remer KA; Brcic M; Sauter KS; Jungi TW
    J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous interleukin-6, but not tumor necrosis factor alpha, contributes to the development of toll-like receptor 4/myeloid differentiation factor 88-mediated acute arthritis in mice.
    Kyo F; Futani H; Matsui K; Terada M; Adachi K; Nagata K; Sano H; Tateishi H; Tsutsui H; Nakanishi K
    Arthritis Rheum; 2005 Aug; 52(8):2530-40. PubMed ID: 16052598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands.
    de Vos AF; Pater JM; van den Pangaart PS; de Kruif MD; van 't Veer C; van der Poll T
    J Immunol; 2009 Jul; 183(1):533-42. PubMed ID: 19542464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
    Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
    Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.
    Liu-Bryan R; Scott P; Sydlaske A; Rose DM; Terkeltaub R
    Arthritis Rheum; 2005 Sep; 52(9):2936-46. PubMed ID: 16142712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome.
    Netea MG; Kullberg BJ; van der Meer JW
    Eur J Clin Invest; 2005 Nov; 35(11):718-21. PubMed ID: 16269022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.